Navigation Links
Lumena Pharmaceuticals Launches Global Clinical Program to Evaluate Safety and Efficacy of LUM001 in Children with Alagille Syndrome
Date:9/26/2013

ill be eligible for participation in a long-term extension study.  For more information about the IMAGO study, visit the study page at clinicaltrials.gov, a registry of funded research studies in the United States and around the world. Information about the ITCH study will also be available at clinicaltrials.gov once the study starts in the U.S.

"I think that I can speak on behalf of the Alagille syndrome community when I say that we enthusiastically support Lumena's work to develop safe, oral therapies to treat Alagille syndrome, and I am especially glad that the company is planning an extension study that allows for patients to have long-term access to this treatment while it is in development," said Cindy Hahn, founder and CEO of the Alagille Syndrome Alliance.

About LUM001

LUM001 is an inhibitor of the apical sodium-dependent bile acid transporter (ASBT), which recycles intestinal bile acids back into the circulation. LUM001 has been studied in 12 clinical trials in more than 1,400 subjects. In previous trials, LUM001 was shown to be generally safe, and the most common side effect, gastrointestinal disturbance, was usually mild and transient in nature. Clinical studies have demonstrated that LUM001 can reduce serum bile acid levels. Reductions in bile acids may alleviate symptoms and improve liver function in many patients with cholestatic liver disease.

Lumena plans to initiate Phase II studies of LUM001 in adults with primary biliary cirrhosis (PBC), children with progressive familial intrahepatic cholestasis (PFIC), and in patients with primary sclerosing cholangitis (PSC) in late 2013. Lumena has been granted Orphan Drug Designation by the U.S. Food & Drug Administration (FDA) Office of Orphan Product Development for LUM001<
'/>"/>

SOURCE Lumena Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Ampio Pharmaceuticals, Inc. Announces $25 Million Financing
2. KaloBios Pharmaceuticals, Inc. Prices Public Offering of Common Stock
3. SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AMAG Pharmaceuticals, Inc. -- AMAG
4. Anthera Pharmaceuticals Announces Emerging Data from Phase 2 Open-Label Extension Study to be Presented at the ACR/ARHP 2013 Annual Scientific Meeting
5. Isis Pharmaceuticals to Present at the Leerink Swann Rare Disease Roundtable
6. Edison Pharmaceuticals Announces Initiation of NIH-Sponsored EPI-743 Clinical Trial with NIH Undiagnosed Diseases Program Patients
7. Inovio Pharmaceuticals Targets Transformation of Monoclonal Antibody Therapies
8. Servier Voluntary Public Offer for all Outstanding Shares of Egis Pharmaceuticals PLC
9. Boehringer Ingelheim Pharmaceuticals, Inc. colabora con Univision Communications Inc. para lanzar una campaña integrada en español
10. Boehringer Ingelheim Pharmaceuticals, Inc. Collaborates With Univision Communications Inc. To Launch An Integrated Campaign In Spanish
11. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 2014 Medical science liaisons (MSLs) play ... opinion leaders (KOLs) who can provide essential insights ... nature of the MSL function, the changing regulatory ... landscape for creating and maintaining KOL and physician ... oversight responsibility for the MSL function is increasingly ...
(Date:9/19/2014)... "Copay coupons," a drug manufacturer ... drugs among patients with prescription drug coverage, may now be ... report  from the Department of Health and ... anti-kickback laws prohibit suppliers from offering side-payments to ... the federal government. The report ...
(Date:9/19/2014)... 2014 /PRNewswire-iReach/ -- "United States General ... key market data on the United ... report provides value, in millions of ... within market categories – Bronchoscopes, Laryngoscopes, ... Gastroscopes, Duodenoscopes, Laparoscopes, Hysteroscopes, Sinuscopes, Resectoscopes, ...
Breaking Medicine Technology:Role of Medical Science Liaisons Shifting in Healthcare Industry 2PCMA: New OIG Report Cites Drug Manufacturer "Copay Coupon" Use in Medicare Part D 2United States General Surgery Devices Market to 2020 - Endoscopy, Bariatric Surgery, Aesthetic Lasers and Energy, Biopsy Devices, Hernia Repair, Non-Vascular Stents 2United States General Surgery Devices Market to 2020 - Endoscopy, Bariatric Surgery, Aesthetic Lasers and Energy, Biopsy Devices, Hernia Repair, Non-Vascular Stents 3United States General Surgery Devices Market to 2020 - Endoscopy, Bariatric Surgery, Aesthetic Lasers and Energy, Biopsy Devices, Hernia Repair, Non-Vascular Stents 4United States General Surgery Devices Market to 2020 - Endoscopy, Bariatric Surgery, Aesthetic Lasers and Energy, Biopsy Devices, Hernia Repair, Non-Vascular Stents 5
... Jan. 4, 2012 /PRNewswire/ -- CryoLife, Inc. (NYSE: ... company focused on cardiac and vascular surgery, announced today ... the position of Vice President, Research and Development; and ... Vice President, Market Development Surgical Adhesives and Starch Medical ...
... /PRNewswire-Asia/ -- The 2011 Medical Korea Awards ceremony was ... the awards ceremony, 10 outstanding medical tourism service providers ... medical tourism agencies, designated as ,first movers, in the ... Yonsei Severance Hospital (General Director: Park Yong-won) won this ...
Cached Medicine Technology:CryoLife Enhances Management Team with Promotions 2CryoLife Enhances Management Team with Promotions 3CryoLife Enhances Management Team with Promotions 4CryoLife Enhances Management Team with Promotions 5Medical Korea Offers 2011 Awards to Top Medical Tourism Service Providers (Institutions) 2
(Date:9/22/2014)... September 22, 2014 Thousand Oaks ... special offer for Invisalign. Invisalign is a type of ... bite problems. Typical pricing can vary based on the ... of aligners that are needed. During this promotion, Dr. ... , About a fifth of the adult population has ...
(Date:9/22/2014)... Steven Reinberg HealthDay Reporter ... that bacterial pneumonia can raise your risk of heart problems, ... and kill heart cells, increasing the chances of heart failure, ... report. In mice, monkeys and human heart tissue, researchers ... and they tried a vaccine that might one day prevent ...
(Date:9/22/2014)... 2014 Caliper, an internationally recognized talent ... honored once again with the When Work Works Award ... has allowed Caliper to increase business and employee success. ... to meet both work and family commitments effectively. As ... at an all-time high. , “At Caliper, our ...
(Date:9/22/2014)... Tristar Products, Inc. is celebrating the 100th ... as the 'Godfather of Fitness,' with the release of ... 24th at the TriBeCa Film Center® in New York ... the man whose mission was to show the world ... name of the film is derived from one of ...
(Date:9/22/2014)... LifeAnt.com, a life insurance provider based ... article to its website that may cause millions of ... dismayed. Titled “Coffee Drinkers Beware! You’re Paying More for ... average, coffee fans tend to pay higher prices for ... enjoy the tasty beverage. , In fact, as Thomas ...
Breaking Medicine News(10 mins):Health News:Thousand Oaks Cosmetic Dentist, Sharon Shamoiel DDS, Is Now Offering a Special on Invisalign 2Health News:Scientists Spot How Bacterial Pneumonia Damages the Heart 2Health News:Scientists Spot How Bacterial Pneumonia Damages the Heart 3Health News:Caliper Recognized Second Year in a Row For Exemplary Workplace Practices 2Health News:Caliper Recognized Second Year in a Row For Exemplary Workplace Practices 3Health News:Tristar Products Premieres The Jack LaLanne Documentary at TriBeCa Film Center in New York City 2Health News:Tristar Products Premieres The Jack LaLanne Documentary at TriBeCa Film Center in New York City 3Health News:Coffee Drinkers Are Charged More For Life Insurance, Reports LifeAnt.com 2
... behind gender difference isn,t clear, researchers say , , ... 2 diabetes have a 26 percent increased risk of ... findings suggest. , The overall incidence of atrial fibrillation ... while the rate for people without the metabolic condition ...
... developmental origin of specialized skin cells involved in touch sensation. ... of the Journal of Cell Biology (online September ... cells that reside in the vertebrate epidermis, passing mechanical stimuli ... in the paws and around the whiskers but, because they ...
... of Public Health and The Boston Globe finds 59% of Massachusetts ... was enacted in 2006, support it. A little more than one ... level of public support for the law has declined somewhat in ... 2008 to 59% in the current poll. The current number is ...
... the same drugs that have buoyed long-term survival rates ... joint pain so severe that many patients discontinue these ... research, however, has uncovered patterns that may help clinicians ... sooner in order to increase their chances of sticking ...
... New Text ... ... (Axiom), one of the nation,s leaders in clinical research support and integrated healthcare marketing, ... outreach is the future of patient recruitment , due to the growth and convenience ...
... survey shows , MONDAY, Sept. 28 (HealthDay News) -- Parents ... growth charts widely used in pediatrician,s offices, but many parents ... new survey shows. , About 85 percent of parents could ... correctly identify that the point corresponded to the child,s age, ...
Cached Medicine News:Health News:Irregular Heartbeat Risk Higher in Women With Type 2 Diabetes 2Health News:Irregular Heartbeat Risk Higher in Women With Type 2 Diabetes 3Health News:59 percent support Massachusetts' Landmark 2006 health reform law 2Health News:59 percent support Massachusetts' Landmark 2006 health reform law 3Health News:Penn studies point to strategies for reducing painful breast cancer drug side effects 2Health News:Penn studies point to strategies for reducing painful breast cancer drug side effects 3Health News:Axiom Accelerated Patient Recruitment Rolls Out 2Health News:Children's Growth Charts Don't Measure Up With Parents 2Health News:Children's Growth Charts Don't Measure Up With Parents 3
A simple solution to hand assisted laparoscopic surgery....
GelPort hand access laparoscopy combines the patient outcomes of minimally invasive surgery with the speed and precision of open surgery....
... HandPort Systems non-adhesive sealing method ... Laparoscopic Surgrery (HALS) procedures, allowing ... and palpate throughout. Because HALS ... 6 cm, patients experience less ...
The CPAP TREND 110 delivers performance with quiet operation. Can be used together with the SomnoPlus CPAP Mask and AquaTrend Heated Humidifier....
Medicine Products: